Linda F. Williams

Linda F. Williams serves as a Contract Specialist responsible for managing the full lifecycle of federal acquisitions, from requirements validation and market research through solicitation, evaluation, award, and contract administration. She plays a critical role in ensuring compliance with federal procurement regulations while supporting mission-critical scientific and technical objectives. Her portfolio primarily encompasses professional services, laboratory instrumentation, and biological product manufacturing contracts, requiring a nuanced understanding of technical specifications, performance metrics, and regulatory frameworks governing high-complexity procurements. Linda collaborates with a diverse range of vendors, including specialized scientific consultants, analytical instrument manufacturers, and biotechnology producers. While no single contractor dominates her award history, she consistently engages with firms possessing domain expertise in laboratory analytics, research support services, and regulated biological manufacturing. Her contracting approach emphasizes competitive solicitation under full and open competition, fostering transparent and rigorous evaluation processes to ensure value and technical suitability. Linda’s procurement patterns reflect a strong preference for full and open competition, with 100% of her awards issued without set-aside designations such as 8(a), HUBZone, or SDVOSB. This indicates a focus on technical merit and capability over socioeconomic criteria, aligning with mission needs that prioritize specialized expertise and regulatory compliance. While small business participation is not formally prioritized in her portfolio, her evaluations remain grounded in fair and open competition as prescribed by the Federal Acquisition Regulation. Her primary procurement focus lies within NAICS 541990 (Other Professional, Scientific, and Technical Services) and 325414 (Biological Product Manufacturing), reflecting deep engagement with research support, technical consulting, and regulated biopharmaceutical production. She also frequently procures analytical laboratory instruments under NAICS 334516 and partners with academic institutions under NAICS 611310. This technical specialization underscores her expertise in complex, science-driven acquisitions requiring rigorous compliance with FDA, EPA, or other regulatory standards.